Introduction
============

Regenerative medicine promises novel therapies for tissue regeneration, including the potential to replace missing teeth with bioengineered tissues. Tooth formation is guided by reciprocal signaling interactions between the cranial neural crest-derived mesenchymal cells (forming dentin and pulp) and ectoderm-derived dental epithelial cells (forming enamel). Classic tissue recombination experiments have been used to successfully regenerate mouse, rat and pig tooth organs,^[@bib1],[@bib2],[@bib3],[@bib4],[@bib5],[@bib6]^ and demonstrate that both epithelial and mesenchymal components are required for tooth organ regeneration. Dental mesenchymal stem cells from either human exfoliated deciduous or adult dental pulp are available for dentin/pulp complex bioengineering,^[@bib7],[@bib8],[@bib9],[@bib10]^ while a dental epithelial component does not exist in the erupted human tooth for enamel tissue regeneration. Therefore, identification of alternative cell sources for dental epithelial cell regeneration remains a challenge.

Mammalian dental epithelial cells are unique in that they are derived from oral ectoderm and are responsible for the formation of the highly mineralized enamel. The ectoderm-derived oral epithelium located at sites where teeth will form, proliferates and differentiates to form a dental epithelial band (also referred as dental placode), which is the first sign of tooth formation. In communication with adjacent dental mesenchyme, dental epithelial cells progress through multiple stages of differentiation in bud and cap stages of tooth morphogenesis. In the subsequent bell stage, cytodifferentiation of dental epithelial cells results in ameloblast-lineage cells (ALCs), including presecretory, secretory and maturation ameloblasts. Enamel matrix protein secretion and matrix mineralization is initiated by secretory ameloblasts. Secreted matrix proteins self-assemble to form the unique structure of mineralized enamel.

Previous studies have shown that mouse embryonic stem cells and c-kit-positive mouse bone marrow cells can be differentiated into ameloblast-like cells.^[@bib4],[@bib11],[@bib12],[@bib13]^ These studies of stem cells from mouse suggest that human embryonic stem cells (hESCs) could be a viable cell source for regeneration of dental epithelial cells.

hESCs are derived from the inner cell mass of blastocyst-stage human embryos. hESCs can self-renew and give rise to all types of cell in the human body.^[@bib14]^ When induced with bone morphogenetic protein 4 (BMP4) and α-retinoic acid (RA), hESCs differentiate toward cells with an epithelial morphology.^[@bib15]^ Cytokeratin expression is a characteristic of epithelial cells, and the cytokeratin expression pattern of hESC-derived epithelial cells (ES-ECs) has not been characterized and compared with the cytokeratin expression patterns of other epithelia.

Cytokeratins (CKs) are the typical intermediate filament proteins of epithelia, which are known to be expressed in an epithelial type- and stage-specific manner. CKs are chemically very stable, long and unbranched filaments of ∼10 nm in diameter, which are important for maintaining mechanical stability and integrity of epithelial cells and tissues at both the single cell and epithelial sheet levels. The CK gene family consists of 54 distinct functional genes in humans. CKs are heterodimers by pairing one type I keratin and one type II keratin (1∶1) molecule.^[@bib16]^

In this study, we characterized the expression patterns of CKs and genes associated with early enamel organ epithelial differentiation in ES-ECs, as compared to human fetal skin epithelium (SE), fetal oral buccal mucosal epithelial cells (OEs) and ALCs. These results will direct our further studies to explore the potential for using ES-ECs to regenerate ALCs.

Materials and methods
=====================

Maintenance of hESCs
--------------------

The hESC line (WA09) was purchased from the WiCell Research Institute (Madison, WS, USA). The cells were maintained on a layer of mitosis inactivated mouse embryonic fibroblasts (MEFs) in unconditioned medium: Dulbecco\'s modified Eagle\'s medium (DMEM)/Ham\'s F-12 medium containing 20% Knockout serum replacement (Life Technologies, Carlsbad, CA, USA), non-essential amino acids (Millipore, Billerica, MA, USA), 1 mmol⋅L^−1^ L-glutamine, 0.1 mmol⋅L^−1^ beta-mercaptoethanol and 4 ng⋅mL^−1^ basic fibroblast growth factor, 50 mg⋅mL^−1^ penicillin and streptomycin (Sigma-Aldrich, St Louis, MO, USA).^[@bib17]^

Epithelial induction of hESCs
-----------------------------

As described by Metallo and co-workers,^[@bib15]^ BMP4 and α-RA were used to induce differentiation of hESCs to an epithelial lineage. In brief, hESCs were grown for 2 days on Matrigel (BD Biosciences, Franklin Lakes, NJ, USA) coated culture-ware in MEF-conditioned medium. The MEF-conditioned medium was then supplemented with varying concentrations of BMP4 (Life Technologies, Carlsbad, CA, USA) and RA (Sigma-Aldrich, St Louis, MO, USA). In parallel studies, lithium chloride (LiCl), a Wnt signaling activator,^[@bib18]^ was added to the induction medium.

hESCs were induced for 7 days using the following conditions: Group A, 25 ng⋅mL^−1^ BMP4+1 µmol⋅L^−1^ RA; Group B, 25 ng⋅mL^−1^ BMP4+1 µmol⋅L^−1^ RA+100 µmol⋅L^−1^ LiCl; Group C, 25 ng⋅mL^−1^ BMP4+1 µmol⋅L^−1^ RA+1 mmol⋅L^−1^ LiCl; Group D, 12.5 ng⋅mL^−1^ BMP4+1 µmol⋅L^−1^ RA; Group E, 12.5 ng⋅mL^−1^ BMP4+1 µmol⋅L^−1^ RA+100 µmol⋅L^−1^ LiCl; Group F, 12.5 ng⋅mL^−1^ BMP4+1 µmol⋅L^−1^ RA+1 mmol⋅L^−1^ LiCl. Upon induction, cell morphology was recorded daily using a phase contrast microscope. After 7 days\' induction, cells were collected and total RNA was extracted using RNeasy Mini kit (Qiagen, Dusseldorf, Germany) according to manufacturer\'s instruction. SuperScript III First-Strand Synthesis System (Life Technologies, Carlsbad, CA, USA) was used to synthesize cDNA.^[@bib19]^ In brief, 2 µg total RNA, 200 ng random primers, 1 µL 10 mmol⋅L^−1^ dNTP mix, 4 µL 5× first-strand buffer, 1 µL 0.1 mol⋅L^−1^ DTT and 1 µL SuperScript III reverse transcriptase were used to constitute a 20-μL reaction, which was incubated at 50 °C for 1 h.

Quantitative polymerase chain reaction (PCR) was carried out using the ABI 7500 system (Applied Biosystems, Life Technologies, Carlsbad, CA, USA). Primers and TaqMan probes used for detecting endogenous control 18S and target genes were purchased from Applied Biosystems. TaqMan probes can hybridize to the target DNA sequence and emit fluorescence as PCR reaction goes on. The intensity of released fluorescence is proportional to the amount of the PCR amplicon. The real-time guantitative PCR (qPCR) conditions were as follows: 50 °C for 2 min and 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s and 60 °C for 1 min. To quantify the relative expression levels of the target gene, the comparative CT (threshold cycle) method was used. The corresponding arithmetic formulas used are the following: ΔCT=CT~target\ gene~−CT~GAPDH~; and CT~Linear~=2^−(ΔCTcondition1−ΔCTcondition2)^. CT~Linear~value represents the fold change in mRNA expression levels between the two conditions, assuming a doubling of the amplified product with each PCR cycle.

Characterization of amelogenesis-associated genes in differentiated cells
-------------------------------------------------------------------------

Conventional PCR was used to analyze the gene expression of *Fgf8*, a signaling molecule upregulated in placode stage of dental epithelial cells; *Msx1*, *Msx2*, *Shh* and *Pitx2* have been identified to be important factors in early stages of amelogenesis. In addition, gene expression of *amelogenin*, the characteristic enamel matrix protein marker for secretory ameloblasts was determined. The gene of glyceraldehyde-3-phosphate dehydrogenase (*GAPDH)* was used as an endogenous control. A cDNA library of human fetal tooth organs was used as a positive control for *amelogenin* amplification. PCR was performed at 95 °C for 5 min, 34 cycles of 95 °C for 30 s, 57 °C for 30 s and 72 °C for 1 min, followed by 72 °C for 5 min. Primer sequences for target genes are shown in [Table 1](#tbl1){ref-type="table"}. After amplification, equal volumes of PCR products were separated by electrophoresis on agarose gels.

Characterization of CKs in differentiated cells
-----------------------------------------------

All fetal tissues were collected from 16- to 20-week-old human fetal cadavers under guidelines approved by Committee on Human Research at the University of California, San Francisco. Human fetal OEs and ALCs were cultured following previously published protocols.^[@bib20],[@bib21]^ Briefly, dissected fetal oral buccal mucosal epithelia were minced and further dispersed by incubating with 2 mg⋅mL^−1^ collagenase/dispase (Roche, Basel, Switzerland) at 37 °C for 2 h. Dissected tooth organs were digested with 2 mg⋅mL^−1^ collagenase/dispase at 37 °C for 2 h. After washing, the tissue mass was further digested with 0.05% trypsin/ethylene diaminetetraacetic acid (EDTA) for 5 min at 37 °C. Epithelial cells were selectively grown in supplemented keratinocyte growth medium (KGM-2) (Lonza, Basel, Switzerland) with 0.05 mmol⋅L^−1^ calcium, 1% penicillin and streptomycin on BD Primaria Tissue Culture Dishes (BD Biosciences, Franklin Lakes, NJ, USA).

Total RNA was purified from cultured OEs, ALCs and dissected fetal facial SE by using RNeasy Mini RNA kit (Qiagen, Dusseldorf, Germany). cDNA was synthesized by using SuperScript III First-Strand Synthesis System (Life Technologies, Carlsbad, CA, USA), and served as templates to amplify CKs using the same PCR conditions as described above. Primers used to amplify CKs were listed in [Table 2](#tbl2){ref-type="table"}.

Results
=======

hESCs were induced toward an epithelial fate
--------------------------------------------

hESCs were maintained on MEF feeder cells and formed typical tightly packed embryonic stem cell colonies ([Figure 1a](#fig1){ref-type="fig"}). Prior to induction, hESCs were passaged to Matrigel-coated culture ware, and still formed the tightly packed colonies ([Figure 1b](#fig1){ref-type="fig"}). After culture with epithelial induction medium for 7 days, hESCs transformed into a cobble-stone epithelial phenotype ([Figure 1c](#fig1){ref-type="fig"}), and some cells formed concentric cell nests indicated by arrows in [Figure 1d](#fig1){ref-type="fig"}. Expression of CK14, a CK marker for epithelial cells, was upregulated with the induction with BMP4 and RA ([Figure 1e](#fig1){ref-type="fig"}). Expression of CK14 increased an average 44-fold in the cells induced with 12.5 ng⋅mL^−1^ BMP4 and 1 µmol⋅L^−1^ RA as compared to that of undifferentiated hESCs (column D in [Figure 1e](#fig1){ref-type="fig"}). Further increasing the concentration of BMP4 did not significantly enhance the efficiency of differentiation. Additional LiCl had no synergetic effects on upregulation of CK14 in the induced cells.

ES-ECs showed upregulation of early stage of odontogenesis-associated genes *Fgf8* and *Msx1*
---------------------------------------------------------------------------------------------

As shown in [Figure 2](#fig2){ref-type="fig"}, differentiated ES-ECs (lane A--C) expressed *Fgf8* and *Msx1* in addition to *Shh*, *Msx2* and *Pitx 2* that were expressed by non-induced hESCs (lane F). ALCs (lane E) and OEs (lane D) expressed *Msx1, Msx2* and *Pitx2*, but no *Fgf8* and *Shh.* None of inducers including BMP4, RA and LiCl was capable of inducing *amelogenin* expression in those induced epithelial cells.

Although there was no detectable expression of *Fgf8* and *Msx1* in hESCs (lane F), ES-ECs (lane A--C) expressed detectable *Msx1*, similar to that of ALCs (lane E). We did not find any expression of *Shh* in ALCs at mRNA level, though mRNA expression of this molecule was detected in all the induced ES-ECs. *Pitx2* and *Msx2* were detected in all groups (lane A--F). Gene expression of secretory ameloblast specific enamel matrix protein amelogenin was not detected in any of the cultured cells (lane A--F). cDNA library of human fetal tooth bud was used as a positive control for *amelogenin* expression. *GAPDH* used as an endogenous control was detected in all groups with the similar intensity.

Both ES-ECs and ALCs expressed CK76
-----------------------------------

The pattern of CK expression is shown in [Figure 3a](#fig3){ref-type="fig"}. CK71, CK5, CK14, CK7, CK19, CK13, CK2, CK1, CK10, CK6 and CK16 were the CKs that could be detected at mRNA level in all ALCs, OEs, SE and ES-ECs. CK25 was only detected in SE, and CK4 was mainly detected in ALCs and OEs. Expression of CK76 was more intense in ALCs, and was somewhat less intense in ES-ECs and OEs, but was not detected in SE and hESCs ([Figure 3b](#fig3){ref-type="fig"}).

Discussion
==========

The focus of this study was to determine whether the epithelial cells derived from hESCs could be used as a source of epithelial progenitor cells for ameloblasts. In this study, we demonstrated that BMP4 at 12.5 ng⋅mL^−1^ and RA at 1 µmol⋅L^−1^ are sufficient to differentiate hESCs into cells with an epithelial morphology and upregulated CK14. Increased concentrations of BMP4 to 25 ng⋅mL^−1^ did not further enhance the efficiency of induction. BMP4 has been characterized as an inducer of epidermal differentiation.^[@bib22]^ The effect of RA on epithelial lineage specification dependents on the context of bone morphogenetic protein signaling.^[@bib15]^

We conducted further studies to differentiate ES-ECs towards amelogenin-producing cells by using LiCl. LiCl is known to be an activator of Wnt signaling.^[@bib23]^ Wnt signaling plays a critical role during tooth development,^[@bib24],[@bib25],[@bib26],[@bib27],[@bib28],[@bib29]^ as shown by the lack of Lef1, a downstream effector of Wnt signaling pathway, which results in developmental defects in all epithelial appendages including tooth.^[@bib30]^ However, supplementation of LiCl in the inducing medium did not result in the expression of amelogenin in ES-ECs.

The cultured ALCs and ES-ECs did not have any detectable *amelogenin* expression, indicating that neither cell type had reached a stage of differentiation characteristics of secretory ameloblasts. Conditioned medium collected from human ALCs could not induce ES-ECs to express amelogenin. We have found that coculture of ALCs with either Matrigel or dental pulp stem cells can result in upregulated amelogenin expression.^[@bib31]^ Therefore, further differentiation of ES-ECs to secretory ameloblasts likely requires a complex of signaling molecules derived from dental mesenchyme or extracellular matrix.

In addition to *Msx2* and *Pitx2*, ES-ECs expressed odontogenic associated genes including *Fgf8*, *Msx1* and *Shh*. *Fgf8* and *Msx1* have been identified to be critical for the initial stage of tooth formation. Transgenic mice carrying a homozygous *Msx1* germline mutation display a phenotype of complete absence of the incisor.^[@bib32]^ Inactivation of *Fgf8* can severely disturb mandibular and maxillary development with no molar teeth formed, while the incisor remains.^[@bib33]^ Expression of *Fgf8* and *Msx1* in the ES-ECs is a promising finding toward identifying a cell source for ameloblast regeneration. *Shh* is either temporally expressed early at the epithelial thickening stage or later at the enamel knot of tooth formation. *Shh* did not present in human ALCs, which are derived from bell stage of tooth organs. In contrast, ES-ECs do express *Shh*, which further supports the possibility that ES-ECs are similar to early differentiating enamel organ epithelial cells.

We sought to characterize these cells utilizing CKs as markers specific for different types of epithelial cells. For example, CK25 is among the group of CKs that are highly specific for the inner root sheath (IRS) of the hair follicle.^[@bib34]^ The keratinocytes of all three IRS compartments including the Henle layer, the Huxley layer and the IRS cuticle^[@bib35],[@bib36]^ synthesize CK25.^[@bib37]^ Our studies indicated that CK25 was certainly specific to human fetal skin epithelia, which contain hair follicles, while no CK25 expression was detected in hESCs, human fetal OEs, ALCs and ES-ECs, although skin epithelia, mucosal epithelia and ALCs are all derived from ectoderm.

The paired type II keratin CK4 and the type I keratin CK13 indicates a mucosal path of differentiation for the non-keratinizing internal stratified squamous epithelia. A previous study reported that CK4 is present in the entire suprabasal compartment of mucosal stratified squamous epithelia, while it is completely absent in the epidermis.^[@bib38]^ In this study, expression of CK4 in both human oral buccal mucosal epithelial cells and ALCs which originate from the local thickened oral epithelial cells,^[@bib39]^ suggests the same origin of these two epithelial sources. No CK4 was detected in human fetal facial SE, which confirmed that this CK is specific for mucosa and non-keratinized epithelia.

It is interesting that except for SE, all ALCs, OEs and ES-ECs expressed CK76, which is known to be expressed in suprabasal cells of oral masticatory epithelia. Given the fact that OEs and ALCs are derived from the same progenitor cell source, the upregulation of CK76 in ES-ECs suggests that ES-ECs have increased homology to ALCs and OEs, but do not commit to the fate of SE. Combined with the fact that ES-ECs expressed *Fgf8*, *Msx1* and *Shh*, we anticipate that ES-ECs hold the potential to be differentiated into an ameloblast phenotype.

Conclusion
==========

In this study, we have identified the effective concentrations of BMP4 and RA to drive differentiation of hESCs toward an epithelial lineage phenotype. We found that this protocol could increase the expression of *Fgf8*, *Shh* and *Msx1* in ES-ECs. Expression of *Msx1* in ES-ECs was similar to the levels found in ALCs. ES-ECs had upregulated expression of CK76, a CK that is differentially expressed in ALCs as compared to SE. These studies suggest that these ES-ECs are useful as an alternative cell source to regenerate enamel-forming cells as availability of dental epithelial cells in humans is significantly constrained. Studies to identify factors including the human dental mesenchyme that can promote the further differentiation of ES-ECs will further facilitate the use of hESCs and ES-ECs for tooth tissue regeneration.
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![**hESCs adopted an epithelial phenotype after induction.** (**a**) hESCs grown on mouse embryonic fibroblast feeder layer formed well-defined embryonic stem cell colonies containing epithelioid cells on the periphery and polygonal cells within the colony. (**b**) After being transferred to a feeder-free culture-ware, hESCs on Matrigel grew as monolayer. Colonies were well formed. Monolayer hESCs had dominant nuclei containing reticulated nucleoli with a high nucleus-to-cytosol ratio. (**c**) After culture with either 25 or 12.5 ng⋅mL^−1^ BMP4 and 1 µmol⋅L^−1^ RA for 7 days, hESCs adopted a cobble-stone like morphology. (**d**) A representative phase contrast microscopy image is shown of hESCs induced with 12.5 ng⋅mL^−1^ BMP4 and 1 µmol⋅L^−1^ RA and formed concentric cell nests indicated by red arrows. (**e**) CK14 expression was significantly upregulated upon the induction. Induction with 12.5 ng⋅mL^−1^ BMP4 and 1 µmol⋅L^−1^ RA resulted in an average 44-fold upregulation of CK14 as compared to that of control hESCs (column D). The columns represent mean values plus standard deviation of three independent experiments. Further increasing the concentration of BMP4 did not significantly enhance the efficiency of differentiation. Additional LiCl had no synergetic effects on the upregulation of CK14 in the induced cells. Column A, treated with 25 ng⋅mL^−1^ BMP4 +1 mmol⋅L^−1^ RA; Column B, treated with 25 ng⋅mL^−1^ BMP4 +1 mmol⋅L^−1^ RA + 100 μmol⋅L^−1^ LiCl; Column C, treated with 25 ng⋅mL^−1^ BMP4 +1 mmol⋅L^−1^ RA + 1 mmol⋅L^−1^ LiCl; Column D, treated with 12.5 ng⋅mL^−1^ BMP4 +1 mmol⋅L^−1^ RA; Column E, treated with 12.5 ng⋅mL^−1^ BMP4 +1 mmol⋅L^−1^ RA + 100 μmol⋅L^−1^ LiCl; Column F, treated with 12.5 ng⋅mL^−1^ BMP4 +1 mmol⋅L^−1^ RA + 1 mmol⋅L^−1^ LiCl. Scale bar: 50 µm. BMP4, bone morphogenetic protein 4; hESC, human embryonic stem cell; LiCl, lithium chloride; RA, retinoic acid.](ijos201314f1){#fig1}

![**hESCs were induced to express genes associated with odontogenesis indicated by conventional PCR and agarose gel electrophoresis.** hESCs were induced with 12.5 ng⋅mL^−1^ BMP4 and 1 µmol⋅L^−1^ RA (lane A), 12.5 ng⋅mL^−1^ BMP4, 1 µmol⋅L^−1^ RA and 100 µmol⋅L^−1^ LiCl (lane B), 12.5 ng⋅mL^−1^ BMP4, 1 µmol⋅L^−1^ RA and 1 mmol⋅L^−1^ LiCl (lane C). Oral epithelial cells (lane D), ALCs (lane E) and non-induced hESCs (lane F) were compared with ES-ECs in the expression of genes related to odontogenesis. *Fgf8* and *Msx1* were expressed in the induced ES-ECs (lane A--C), while no expression was detected in undifferentiated hESCs (lane F). Both ES-ECs (lane A--C) and non-induced hESCs (lane F) had detectable *Shh* expression. *Pitx2* and *Msx2* were detected in all cells. None of cultured cells had detectable *amelogenin* expression. *Amelogenin* expression was only detected in the positive control using human fetal tooth bud cDNA library as template (lane G). *GAPDH* was detected in all groups with equal intensity. BMP4, bone morphogenetic protein 4; ES-EC, hESC-derived epithelial cell; hESC, human embryonic stem cell; LiCl, lithium chloride; RA, retinoic acid.](ijos201314f2){#fig2}

![**Conventional PCR analysis shows the expression pattern of CKs in human ALCs, fetal OEs, fetal SE and ES-ECs.** (**a**) CK25 was only present in SE while absent in ALCs, OEs and ES-ECs. CK4 was present in both ALCs and OEs, while absent in SE and ES-ECs. (**b**) One representative DNA electrophoresis image shows that CK76 was present in ALCs, ES-ECs and OEs, while absent in SE and hESCs. ALC, ameloblast-lineage cell; BMP4, bone morphogenetic protein 4; CK, cytokeratin; ES-EC, hESC-derived epithelial cell; hESC, human embryonic stem cell; OE, oral epithelial cell; SE, skin epithelium.](ijos201314f3){#fig3}

###### Sequences of primers used to amplify genes associated to odontogenesis

  Genes          Sequences of primers        Size/bp
  --------- ------------------------------- ---------
  *Amg*      Forward GGCTGCACCACCAAATCATCC     383
             Reverse CCCGCTTGGTCTTGTCTGTCG       
  *Fgf8*     Forward GTTGCACTTGCTGGTCCTCT      220
             Reverse GAGTTGGTAGGTCCGGATGA        
  *Msx1*     Forward TCCTCAAGCTGCCAGAAGAT      342
             Reverse TCTCCAGCTCTGCCTCTTGT        
  *Shh*      Forward CCAATTACAACCCCGACATC      339
             Reverse CCGAGTTCTCTGCTTTCACC        
  *Msx2*     Forward ACACAAGACCAATCGGAAGC      222
             Reverse GCAGCCATTTTCAGCTTTTC        
  *Pitx2*    Forward ACTTTACCAGCCAGCAGCTC      369
             Reverse GTGGGGAAAACATGCTCTGT        
  *GAPDH*    Forward ACCACAGTCCATGCCATCAC      452
             Reverse TCCACCACCCTGTTGCTGTA        

###### Sequences of primers used to patterning cytokeratins

  Genes          Sequences of primers       Size/bp
  --------- ------------------------------ ---------
  *Krt2*     Forward TTAGTGTGGCTGGAGGAGGT     485
             Reverse GCTGTCGATATACCCCTGGA       
  *Krt76*    Forward GGTGGTCCTGGTGTATTTGG     324
             Reverse GGATTCAAAACAAGGCTCCA       
  *Krt1*     Forward AGGAGGTGGACGTGGTAGTG     335
             Reverse AGGAGGCAAATTGGTTGTTG       
  *Krt10*    Forward AGCATGGCAACTCACATCAG     324
             Reverse TCATTTCCTCCTCGTGGTTC       
  *Krt6*     Forward TCAGGTCACCGTCAACAAGA     319
             Reverse CATGTTCCTCAGCTCCGAAT       
  *Krt16*    Forward AGCCCATTTTGCAGATTGAC     365
             Reverse GAACCAGGTCTCAGCGTCTC       
  *Krt25*    Forward CCTGGTTCAACGAGAAGAGC     484
             Reverse CTGCGTTGGTCTACCTCCTC       
  *Krt71*    Forward CCACTCTCAGCTCCATCTCC     379
             Reverse GGCCACTCTTGGTTGTTTGT       
  *Krt14*    Forward CAGTTCACCTCCTCCAGCTC     348
             Reverse GAGGTTCTGCATGGTCACCT       
  *Krt19*    Forward GAATCGCAGCTTCTGAGACC     345
             Reverse GCACCTTGTCCAGGTAGGAG       
  *Krt7*     Forward CAGGAACTCATGAGCGTGAA     346
             Reverse GGGTGGGAATCTTCTTGTGA       
  *Krt5*     Forward CTTGTGGAGTGGGTGGCTAT     440
             Reverse CCACTTGGTGTCCAGAACCT       
  *Krt4*     Forward CTACAACCTCAGGGGGAACA     401
             Reverse GCTCAAGGTTTTTGCTGGAG       
  *Krt13*    Forward TGATTGGTTTCCCTTCCTCA     400
             Reverse TGCAGAAAGGCAGGAAACTT       
